Mechanical stimulation in the engineering of heart muscle

Advanced Drug Delivery Reviews

Volumn 96, Issue , 2016, Pages 156-160

  Liaw, Norman Yu ^a,b   Zimmermann, Wolfram Hubertus ^a,b  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

Author keywords

Cardiac; Engineered heart muscle; Mechanical stimulation; Tissue engineering

Indexed keywords

BLOOD PRESSURE; HEART; MUSCLE; TISSUE;

ARTERIAL BLOOD PRESSURE; BLOOD-FILLED CHAMBERS; CARDIAC; DESIGN AND EVALUATIONS; HEART MUSCLES; MECHANICAL STIMULATION; PHYSIOLOGICAL PROCESS; UNDERLYING PRINCIPLES;

TISSUE ENGINEERING;

ARTERIAL PRESSURE; BIOENGINEERING; BIOMECHANICS; BIOPHYSICS; CELL MATURATION; EVOKED RESPONSE; HEART AFTERLOAD; HEART CONTRACTION; HEART DEVELOPMENT; HEART DISEASE; HEART ELECTROPHYSIOLOGY; HEART FUNCTION; HEART MUSCLE; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILE FORCE; HEART OUTPUT; HEART PRELOAD; HEART STIMULATION; HEART VENTRICLE; HUMAN; HYDROGEL; MECHANICAL STIMULATION; MECHANICAL STRESS; MUSCLE STRESS; NONHUMAN; PHENOMENOLOGY; PRIORITY JOURNAL; REVIEW; SINUS NODE; TISSUE ENGINEERING; ANIMAL; BIOLOGICAL MODEL; CARDIAC MUSCLE CELL; CYTOLOGY; HEART VENTRICLE FUNCTION; PHYSIOLOGY; PROCEDURES;

ANIMALS; BIOMECHANICAL PHENOMENA; BIOPHYSICAL PHENOMENA; HEART VENTRICLES; HUMANS; MODELS, CARDIOVASCULAR; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; TISSUE ENGINEERING; VENTRICULAR FUNCTION;

EID: 84951800301     PISSN: 0169409X     EISSN: 18728294     Source Type: Journal    
DOI: 10.1016/j.addr.2015.09.001     Document Type: Review

References (65)

1. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., Waknitz M.A., Swiergiel J.J., Marshall V.S., Jones J.M. Embryonic stem cell lines derived from human blastocysts. Science 1998, 282:1145-1147.
2. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131:861-872.
3. Kattman S.J., Witty A.D., Gagliardi M., Dubois N.C., Niapour M., Hotta A., Ellis J., Keller G. Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines. Cell Stem Cell 2011, 8:228-240.
4. Lian X., Bao X., Zilberter M., Westman M., Fisahn A., Hsiao C., Hazeltine L.B., Dunn K.K., Kamp T.J., Palecek S.P. Chemically defined, albumin-free human cardiomyocyte generation. Nat. Methods 2015, 12:595-596.
5. Burridge P.W., Matsa E., Shukla P., Lin Z.C., Churko J.M., Ebert A.D., Lan F., Diecke S., Huber B., Mordwinkin N.M., Plews J.R., Abilez O.J., Cui B., Gold J.D., Wu J.C. Chemically defined generation of human cardiomyocytes. Nat. Methods 2014, 11:855-860.
6. Burridge P.W., Keller G., Gold J.D., Wu J.C. Production of de novo cardiomyocytes: human pluripotent stem cell differentiation and direct reprogramming. Cell Stem Cell 2012, 10:16-28.
7. Eschenhagen T., Fink C., Remmers U., Scholz H., Wattchow J., Weil J., Zimmermann W., Dohmen H.H., Schafer H., Bishopric N., Wakatsuki T., Elson E.L. Three-dimensional reconstitution of embryonic cardiomyocytes in a collagen matrix: a new heart muscle model system. FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol. 1997, 11:683-694.
8. Zimmermann W.H., Fink C., Kralisch D., Remmers U., Weil J., Eschenhagen T. Three-dimensional engineered heart tissue from neonatal rat cardiac myocytes. Biotechnol. Bioeng. 2000, 68:106-114.
9. Bursac N., Papadaki M., Cohen R.J., Schoen F.J., Eisenberg S.R., Carrier R., Vunjak-Novakovic G., Freed L.E. Cardiac muscle tissue engineering: toward an in vitro model for electrophysiological studies. Am. J. Physiol. 1999, 277:H433-H444.
10. Carrier R.L., Papadaki M., Rupnick M., Schoen F.J., Bursac N., Langer R., Freed L.E., Vunjak-Novakovic G. Cardiac tissue engineering: cell seeding, cultivation parameters, and tissue construct characterization. Biotechnol. Bioeng. 1999, 64:580-589.
11. Leor J., Aboulafia-Etzion S., Dar A., Shapiro L., Barbash I.M., Battler A., Granot Y., Cohen S. Bioengineered cardiac grafts: a new approach to repair the infarcted myocardium?. Circulation 2000, 102:III56-III61.
12. Li R.K., Jia Z.Q., Weisel R.D., Mickle D.A., Choi A., Yau T.M. Survival and function of bioengineered cardiac grafts. Circulation 1999, 100:II63-II69.
13. Shimizu T., Yamato M., Isoi Y., Akutsu T., Setomaru T., Abe K., Kikuchi A., Umezu M., Okano T. Fabrication of pulsatile cardiac tissue grafts using a novel 3-dimensional cell sheet manipulation technique and temperature-responsive cell culture surfaces. Circ. Res. 2002, 90.
14. Zimmermann W.H., Melnychenko I., Wasmeier G., Didie M., Naito H., Nixdorff U., Hess A., Budinsky L., Brune K., Michaelis B., Dhein S., Schwoerer A., Ehmke H., Eschenhagen T. Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nat. Med. 2006, 12:452-458.
15. Zimmermann W.H., Schneiderbanger K., Schubert P., Didie M., Munzel F., Heubach J.F., Kostin S., Neuhuber W.L., Eschenhagen T. Tissue engineering of a differentiated cardiac muscle construct. Circ. Res. 2002, 90:223-230.
16. Radisic M., Park H., Gerecht S., Cannizzaro C., Langer R., Vunjak-Novakovic G. Biomimetic approach to cardiac tissue engineering, Philosophical Transactions of the Royal Society of London. Ser. B Biol. Sci. 2007, 362:1357-1368.
17. Zimmermann W.H., Eschenhagen T. Cardiac tissue engineering for replacement therapy. Heart Fail. Rev. 2003, 8:259-269.
18. Naito H., Melnychenko I., Didie M., Schneiderbanger K., Schubert P., Rosenkranz S., Eschenhagen T., Zimmermann W.H. Optimizing engineered heart tissue for therapeutic applications as surrogate heart muscle. Circulation 2006, 114:I72-I78.
19. Zhang D., Shadrin I.Y., Lam J., Xian H.Q., Snodgrass H.R., Bursac N. Tissue-engineered cardiac patch for advanced functional maturation of human ESC-derived cardiomyocytes. Biomaterials 2013, 34:5813-5820.
20. Anderson R.H., Webb S., Brown N.A., Lamers W., Moorman A. Development of the heart: (3) formation of the ventricular outflow tracts, arterial valves, and intrapericardial arterial trunks. Heart 2003, 89:1110-1118.
21. Anderson R.H., Webb S., Brown N.A., Lamers W., Moorman A. Development of the heart: (2) septation of the atriums and ventricles. Heart 2003, 89:949-958.
22. Moorman A., Webb S., Brown N.A., Lamers W., Anderson R.H. Development of the heart: (1) formation of the cardiac chambers and arterial trunks. Heart 2003, 89:806-814.
23. Goenezen S., Rennie M.Y., Rugonyi S. Biomechanics of early cardiac development. Biomech. Model. Mechanobiol. 2012, 11:1187-1204.
24. Hove J.R., Koster R.W., Forouhar A.S., Acevedo-Bolton G., Fraser S.E., Gharib M. Intracardiac fluid forces are an essential epigenetic factor for embryonic cardiogenesis. Nature 2003, 421:172-177.
25. Kamino K., Hirota A., Fujii S. Localization of pacemaking activity in early embryonic heart monitored using voltage-sensitive dye. Nature 1981, 290:595-597.
26. Maron B.J., Hutchins G.M. The development of the semilunar valves in the human heart. Am. J. Pathol. 1974, 74:331-344.
27. Kowalski W.J., Pekkan K., Tinney J.P., Keller B.B. Investigating developmental cardiovascular biomechanics and the origins of congenital heart defects. Front. Physiol. 2014, 5:408.
28. Dubose T.J., Cunyus J.A., Johnson L.F. Embryonic heart-rate and age. J. Diagn. Med. Sonog. 1990, 6:151-157.
29. Pildner von Steinburg S., Boulesteix A.L., Lederer C., Grunow S., Schiermeier S., Hatzmann W., Schneider K.T., Daumer M. What is the "normal" fetal heart rate?. PeerJ 2013, 1.
30. Afors K., Chandraharan E. Use of continuous electronic fetal monitoring in a preterm fetus: clinical dilemmas and recommendations for practice. J. Pregnancy 2011, 2011:848794.
31. Intengan H.D., Deng L.Y., Li J.S., Schiffrin E.L. Mechanics and composition of human subcutaneous resistance arteries in essential hypertension. Hypertension 1999, 33:569-574.
32. Intengan H.D., Thibault G., Li J.S., Schiffrin E.L. Resistance artery mechanics, structure, and extracellular components in spontaneously hypertensive rats: effects of angiotensin receptor antagonism and converting enzyme inhibition. Circulation 1999, 100:2267-2275.
33. Nissen R., Cardinale G.J., Udenfriend S. Increased turnover of arterial collagen in hypertensive rats. Proc. Natl. Acad. Sci. U. S. A. 1978, 75:451-453.
34. Tobita K., Liu L.J., Janczewski A.M., Tinney J.P., Nonemaker J.M., Augustine S., Stolz D.B., Shroff S.G., Keller B.B. Engineered early embryonic cardiac tissue retains proliferative and contractile properties of developing embryonic myocardium. Am. J. Physiol. Heart Circ. Physiol. 2006, 291:H1829-H1837.
35. Chien S. Mechanotransduction and endothelial cell homeostasis: the wisdom of the cell. Am. J. Physiol. Heart Circ. Physiol. 2007, 292:H1209-H1224.
36. Yoshida H., Manasek F., Arcilla R.A. Intracardiac flow patterns in early embryonic life. Reexamination Circ. Res. 1983, 53:363-371.
37. Hogers B., DeRuiter M.C., Baasten A.M., Gittenberger-de Groot A.C., Poelmann R.E. Intracardiac blood flow patterns related to the yolk sac circulation of the chick embryo. Circ. Res. 1995, 76:871-877.
38. Hogers B., DeRuiter M.C., Gittenberger-de Groot A.C., Poelmann R.E. Extraembryonic venous obstructions lead to cardiovascular malformations and can be embryolethal. Cardiovasc. Res. 1999, 41:87-99.
39. Tiburcy M., Didie M., Boy O., Christalla P., Doker S., Naito H., Karikkineth B.C., El-Armouche A., Grimm M., Nose M., Eschenhagen T., Zieseniss A., Katschinksi D.M., Hamdani N., Linke W.A., Yin X., Mayr M., Zimmermann W.H. Terminal differentiation, advanced organotypic maturation, and modeling of hypertrophic growth in engineered heart tissue. Circ. Res. 2011, 109:1105-1114.
40. Engelmann G.L., Vitullo J.C., Gerrity R.G. Age-related changes in ploidy levels and biochemical parameters in cardiac myocytes isolated from spontaneously hypertensive rats. Circ. Res. 1986, 58:137-147.
41. Adler C.P., Friedburg H. Myocardial DNA content, ploidy level and cell number in geriatric hearts: post-mortem examinations of human myocardium in old age. J. Mol. Cell. Cardiol. 1986, 18:39-53.
42. Soonpaa M.H., Kim K.K., Pajak L., Franklin M., Field L.J. Cardiomyocyte DNA synthesis and binucleation during murine development. Am. J. Physiol. 1996, 271:H2183-H2189.
43. Toischer K., Rokita A.G., Unsold B., Zhu W., Kararigas G., Sossalla S., Reuter S.P., Becker A., Teucher N., Seidler T., Grebe C., Preuss L., Gupta S.N., Schmidt K., Lehnart S.E., Kruger M., Linke W.A., Backs J., Regitz-Zagrosek V., Schafer K., Field L.J., Maier L.S., Hasenfuss G. Differential cardiac remodeling in preload versus afterload. Circulation 2010, 122:993-1003.
44. Zimmermann W.H. Biomechanical regulation of in vitro cardiogenesis for tissue-engineered heart repair. Stem Cell Res. Ther. 2013, 4:137.
45. Janssen P.M. Myocardial contraction-relaxation coupling. Am. J. Physiol. Heart Circ. Physiol. 2010, 299:H1741-H1749.
46. Sagawa K., Lie R.K., Schaefer J. Translation of Otto Frank's paper "Die Grundform des Arteriellen Pulses" Zeitschrift fur Biologie 37: 483-526 (1899). J. Mol. Cell. Cardiol. 1990, 22:253-254.
47. Kobirumaki-Shimozawa F., Inoue T., Shintani S.A., Oyama K., Terui T., Minamisawa S., Ishiwata S., Fukuda N. Cardiac thin filament regulation and the Frank-Starling mechanism. J. Physiol. Sci. JPS 2014, 64:221-232.
48. Holubarsch C., Ruf T., Goldstein D.J., Ashton R.C., Nickl W., Pieske B., Pioch K., Ludemann J., Wiesner S., Hasenfuss G., Posival H., Just H., Burkhoff D. Existence of the Frank-Starling mechanism in the failing human heart. Investig. Organ Tissue Sarcomere Levels Circ. 1996, 94:683-689.
49. Weil J., Eschenhagen T., Hirt S., Magnussen O., Mittmann C., Remmers U., Scholz H. Preserved Frank-Starling mechanism in human end stage heart failure. Cardiovasc. Res. 1998, 37:541-548.
50. Tulloch N.L., Muskheli V., Razumova M.V., Korte F.S., Regnier M., Hauch K.D., Pabon L., Reinecke H., Murry C.E. Growth of engineered human myocardium with mechanical loading and vascular coculture. Circ. Res. 2011, 109:47-59.
51. Endoh M. Force-frequency relationship in intact mammalian ventricular myocardium: physiological and pathophysiological relevance. Eur. J. Pharmacol. 2004, 500:73-86.
52. Mulieri L.A., Hasenfuss G., Leavitt B., Allen P.D., Alpert N.R. Altered myocardial force-frequency relation in human heart failure. Circulation 1992, 85:1743-1750.
53. Wiegerinck R.F., Cojoc A., Zeidenweber C.M., Ding G., Shen M., Joyner R.W., Fernandez J.D., Kanter K.R., Kirshbom P.M., Kogon B.E., Wagner M.B. Force frequency relationship of the human ventricle increases during early postnatal development. Pediatr. Res. 2009, 65:414-419.
54. Godier-Furnemont A.F., Tiburcy M., Wagner E., Dewenter M., Lammle S., El-Armouche A., Lehnart S.E., Vunjak-Novakovic G., Zimmermann W.H. Physiologic force-frequency response in engineered heart muscle by electromechanical stimulation. Biomaterials 2015, 60:82-91.
55. Radisic M., Park H., Shing H., Consi T., Schoen F.J., Langer R., Freed L.E., Vunjak-Novakovic G. Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:18129-18134.
56. Hirt M.N., Boeddinghaus J., Mitchell A., Schaaf S., Bornchen C., Muller C., Schulz H., Hubner N., Stenzig J., Stoehr A., Neuber C., Eder A., Luther P.K., Hansen A., Eschenhagen T. Functional improvement and maturation of rat and human engineered heart tissue by chronic electrical stimulation. J. Mol. Cell. Cardiol. 2014, 74:151-161.
57. Nunes S.S., Miklas J.W., Liu J., Aschar-Sobbi R., Xiao Y., Zhang B., Jiang J., Masse S., Gagliardi M., Hsieh A., Thavandiran N., Laflamme M.A., Nanthakumar K., Gross G.J., Backx P.H., Keller G., Radisic M. Biowire: a platform for maturation of human pluripotent stem cell-derived cardiomyocytes. Nat. Methods 2013, 10:781-787.
58. Tulloch N.L., Pabon L., Murry C.E. Get with the (re)program: cardiovascular potential of skin-derived induced pluripotent stem cells. Circulation 2008, 118:472-475.
59. Yildirim Y., Naito H., Didie M., Karikkineth B.C., Biermann D., Eschenhagen T., Zimmermann W.H. Development of a biological ventricular assist device: preliminary data from a small animal model. Circulation 2007, 116:I16-I23.
60. Black L.D., Meyers J.D., Weinbaum J.S., Shvelidze Y.A., Tranquillo R.T. Cell-induced alignment augments twitch force in fibrin gel-based engineered myocardium via gap junction modification. Tissue Eng. A 2009, 15:3099-3108.
61. Gonen-Wadmany M., Gepstein L., Seliktar D. Controlling the cellular organization of tissue-engineered cardiac constructs. Ann. N. Y. Acad. Sci. 2004, 1015:299-311.
62. Ye L., Zimmermann W.H., Garry D.J., Zhang J. Patching the heart: cardiac repair from within and outside. Circ. Res. 2013, 113:922-932.
63. Mummery C., Ward-van Oostwaard D., Doevendans P., Spijker R., van den Brink S., Hassink R., van der Heyden M., Opthof T., Pera M., de la Riviere A.B., Passier R., Tertoolen L. Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells. Circulation 2003, 107:2733-2740.
64. Weber C.R., Piacentino V., Houser S.R., Bers D.M. Dynamic regulation of sodium/calcium exchange function in human heart failure. Circulation 2003, 108:2224-2229.
65. Razeghi P., Young M.E., Alcorn J.L., Moravec C.S., Frazier O.H., Taegtmeyer H. Metabolic gene expression in fetal and failing human heart. Circulation 2001, 104:2923-2931.